Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivo

Tissue Engineering - Part A

Volumn 16, Issue 4, 2010, Pages 1349-1361

  Martinez, Eliana C ^a   Wang, Jing ^a   Gan, Shu Uin ^a   Singh, Rajeev ^a,b   Lee, Chuen Neng ^a,b   Kofidis, Theo ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLUMINESCENCE; BLOOD VESSELS; CELL DEATH; ENDOTHELIAL CELLS; GRAFTING (CHEMICAL); KETONES; ORGANIC ACIDS; PHOSPHORESCENCE;

APOPTOTIC CELLS; ARTIFICIAL GRAFTS; ASCORBIC ACIDS; AUTOLOGOUS GRAFTS; BIOARTIFICIAL; BIOLUMINESCENCE IMAGING; CELL SURVIVAL; CELL THERAPY; DONOR CELLS; GREEN FLUORESCENT PROTEIN; GROWTH MEDIUM; IN-VITRO; IN-VIVO; MYOCARDIAL GRAFTS; NEOVASCULARIZATION; NEW MODEL; PHOSPHATE-BUFFERED SALINES; PHOTON EMISSIONS; POST-IMPLANTATION; TISSUE TRANSPLANTATIONS; VASCULARIZATION; WISTAR RAT;

GRAFTS;

RATTUS NORVEGICUS;

ASCORBIC ACID; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; GRAFT SURVIVAL; HEART MUSCLE; IN VITRO STUDY; MALE; METABOLISM; METHODOLOGY; MYOBLAST; PHENOTYPE; RAT; TISSUE ENGINEERING; TRANSPLANTATION; WISTAR RAT;

ANIMALS; ASCORBIC ACID; CELL LINE; CELL SURVIVAL; EMBRYONIC STEM CELLS; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; MALE; MYOBLASTS, CARDIAC; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77950836038     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0399     Document Type: Article

References (44)

1. Zimmermann, W.H., Didie, M., Doker, S., Melnychenko, I., Naito, H., Rogge, C., Tiburcy, M., and Eschenhagen, T. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 71, 419, 2006.
2. Muller-Ehmsen, J., Whittaker, P., Kloner, R.A., Dow, J.S., Sakoda, T., Long, T.I., Laird, P.W., and Kedes, L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34, 107, 2002.
3. Suzuki, K., Murtuza, B., Beauchamp, J.R., Brand, N.J., Barton, P.J., Varela-Carver, A., Fukushima, S., Coppen, S.R., Partridge, T.A., and Yacoub, M.H. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110, II219, 2004.
4. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
5. Robey, T.E., Saiget, M.K., Reinecke, H., and Murry, C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45, 567, 2008.
6. Frangogiannis, N.G. The immune system and cardiac repair. Pharmacol Res 58, 88, 2008.
7. Bursac, N., Papadaki, M., Cohen, R.J., Schoen, F.J., Eisenberg, S.R., Carrier, R., Vunjak-Novakovic, G., and Freed, L.E. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 277, H433, 1999.
8. Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H., Gepstein, L., and Levenberg, S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100, 263, 2007.
9. Arrigoni, O., and De Tullio, M.C. Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta 1569, 1, 2002.
10. Vassilopoulos, A., and Papazafiri, P. Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes Hif-1alpha. Free Radic Res 39, 1273, 2005.
11. Fiorito, C., Rienzo, M., Crimi, E., Rossiello, R., Balestrieri, M.L., Casamassimi, A., Muto, F., Grimaldi, V., Giovane, A., Farzati, B., Mancini, F.P., and Napoli, C. Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res 42, 754, 2008.
12. Telang, S., Clem, A.L., Eaton, J.W., and Chesney, J. Depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model. Neoplasia 9, 47, 2007.
13. Omeroglu, S., Peker, T., Turkozkan, N., and Omeroglu, H. High-dose vitamin C supplementation accelerates the Achilles tendon healing in healthy rats. Arch Orthop Trauma Surg 2, 281, 2008.
14. Vissers, M.C., Gunningham, S.P., Morrison, M.J., Dachs, G.U., and Currie, M.J. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic Biol Med 42, 765, 2007.
15. Shinde, R., Perkins, J., and Contag, C.H. Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays. Biochemistry 45, 11103, 2006.
16. Kutschka, I., Chen, I.Y., Kofidis, T., Arai, T., von Degenfeld, G., Sheikh, A.Y., Hendry, S.L., Pearl, J., Hoyt, G., Sista, R., Yang, P.C., Blau, H.M., Gambhir, S.S., and Robbins, R.C. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114, I167, 2006.
17. Hauck, E.S., Zou, S., Scarfo, K., Nantz, M.H., and Hecker, J.G. Whole animal in vivo imaging after transient, nonviral gene delivery to the rat central nervous system. Mol Ther 16, 1857, 2008.
18. Cao, F., Lin, S., Xie, X., Ray, P., Patel, M., Zhang, X., Drukker, M., Dylla, S.J., Connolly, A.J., Chen, X., Weissman, I.L., Gambhir, S.S., and Wu, J.C. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113, 1005, 2006.
19. Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I.M., Battler, A., Granot, Y., and Cohen, S. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102, III56, 2000.
20. Hodges, R.E., Hood, J., Canham, J.E., Sauberlich, H.E., and Baker, E.M. Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr 24, 432, 1971.
21. Chen, I.Y., Greve, J.M., Gheysens, O., Willmann, J.K., Rodriguez-Porcel, M., Chu, P., Sheikh, A.Y., Faranesh, A.Z., Paulmurugan, R., Yang, P.C., Wu, J.C., and Gambhir, S.S. Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol 11, 178, 2009.
22. Jenkins, D.E., Oei, Y., Hornig, Y.S., Yu, S.F., Dusich, J., Purchio, T., and Contag, P.R. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20, 733, 2003.
23. Kang, P.M., and Izumo, S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9, 177, 2003.
24. McClintock, D.S., Santore, M.T., Lee, V.Y., Brunelle, J., Budinger, G.R., Zong, W.X., Thompson, C.B., Hay, N., and Chandel, N.S. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 22, 94, 2002.
25. Malhotra, R., Tyson, D.W., Rosevear, H.M., and Brosius, F.C., III. Hypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells. BMC Cardiovasc Disord 8, 9, 2008.
26. Graham, R.M., Frazier, D.P., Thompson, J.W., Haliko, S., Li, H., Wasserlauf, B.J., Spiga, M.G., Bishopric, N.H., and Webster, K.A. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 207, 3189, 2004.
27. Huang, J., Agus, D.B., Winfree, C.J., Kiss, S., Mack, W.J., McTaggart, R.A., Choudhri, T.F., Kim, L.J., Mocco, J., Pinsky, D.J., Fox, W.D., Israel, R.J., Boyd, T.A., Golde, D.W., and Connolly, E.S., Jr. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A 98, 11720, 2001.
28. Kim, E.J., Won, R., Sohn, J.H., Chung, M.A., Nam, T.S., Lee, H.J., and Lee, B.H. Anti-oxidant effect of ascorbic and dehydroascorbic acids in hippocampal slice culture. Biochem Biophys Res Commun 366, 8, 2008.
29. Asmis, R., and Wintergerst, E.S. Dehydroascorbic acid prevents apoptosis induced by oxidized low-density lipoprotein in human monocyte-derived macrophages. Eur J Biochem 255, 147, 1998.
30. Gogou, E., Hatzoglou, C., Chamos, V., Zarogiannis, S., Gourgoulianis, K.I., and Molyvdas, P.A. The contribution of ascorbic acid and dehydroascorbic acid to the protective role of pleura during inflammatory reactions. Med Hypotheses 68, 860, 2007.
31. Martino, L., Novelli, M., Masini, M., Chimenti, D., Piaggi, S., Masiello, P., and De Tata, V. Dehydroascorbate protection against dioxin-induced toxicity in the beta-cell line INS-1E. Toxicol Lett 189, 27, 2009.
32. Kc, S., Carcamo, J.M., and Golde, D.W. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 19, 1657, 2005.
33. Puskas, F., Gergely, P., Jr., Banki, K., and Perl, A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J 14, 1352, 2000.
34. Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R., and Lee, R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107, 1912, 2003.
35. Shim, W.S., Jiang, S., Wong, P., Tan, J., Chua, Y.L., Tan, Y.S., Sin, Y.K., Lim, C.H., Chua, T., Teh, M., Liu, T.C., and Sim, E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324, 481, 2004.
36. Leong, C.W., Wong, C.H., Lao, S.C., Leong, E.C., Lao, I.F., Law, P.T., Fung, K.P., Tsang, K.S., Waye, M.M., Tsui, S.K., Wang, Y.T., and Lee, S.M. Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts. Biochem Biophys Res Commun 360, 173, 2007.
37. Kutschka, I., Kofidis, T., Chen, I.Y., von Degenfeld, G., Zwierzchoniewska, M., Hoyt, G., Arai, T., Lebl, D.R., Hendry, S.L., Sheikh, A.Y., Cooke, D.T., Connolly, A., Blau, H.M., Gambhir, S.S., and Robbins, R.C. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 114, I174, 2006.
38. Wu, J.C., Chen, I.Y., Sundaresan, G., Min, J.J., De, A., Qiao, J.H., Fishbein, M.C., and Gambhir, S.S. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108, 1302, 2003.
39. Zimmermann, W.H. Remuscularizing failing hearts with tissue engineered myocardium. Antioxid Redox Signal 8, 2011, 2009.
40. Narmoneva, D.A., Vukmirovic, R., Davis, M.E., Kamm, R.D., and Lee, R.T. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110, 962, 2004.
41. Sekiya, S., Shimizu, T., Yamato, M., Kikuchi, A., and Okano, T. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem Biophys Res Commun 341, 573, 2006.
42. Tan, M.Y., Zhi, W., Wei, R.Q., Huang, Y.C., Zhou, K.P., Tan, B., Deng, L., Luo, J.C., Li, X.Q., Xie, H.Q., and Yang, Z.M. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 19, 3234, 2009.
43. Sekine, H., Shimizu, T., Hobo, K., Sekiya, S., Yang, J., Yamato, M., Kurosawa, H., Kobayashi, E., and Okano, T. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118, S145, 2008.
44. Mueller-Stahl, K., Kofidis, T., Akhyari, P., Lee, D.H., Lenz, A., Martinez, E.C., Woitek, F., and Haverich, A. Determinants of bioartificial myocardial graft survival and engraftment in vivo. J Heart Lung Transplant 27, 1242, 2008.